Go Ad-Free
My Alerts
Moneycontrol
Moneycontrol PRO
Get App Open
In App
News on WhatsApp
News on WhatsApp
Go PRO Now
Open App
MARKETS

GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & Drugs

| BSE 2485.00 29.75 (1.21%) | |

BSE Live

Jan 02, 16:01
2485.00 29.75 (1.21%)
Volume
AVERAGE VOLUME
5-Day
4,044
10-Day
3,221
30-Day
6,074
1,238

  • Prev. Close

    2455.25

  • Open Price

    2455.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Jan 02, 15:59
2483.80 27.90 (1.14%)
Volume
AVERAGE VOLUME
5-Day
151,268
10-Day
109,602
30-Day
93,557
27,469

  • Prev. Close

    2455.90

  • Open Price

    2461.30

  • Bid Price (Qty.)

    2483.80 (11)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Cash Flow of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22 Mar 21  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 1,243.74 809.04 837.49 2,470.04 722.33  
Net CashFlow From Operating Activities 1,280.03 578.93 487.94 819.79 594.87  
Net Cash Used In Investing Activities -36.53 14.97 805.19 -419.66 407.57  
Net Cash Used From Financing Activities -769.42 -561.49 -1,544.18 -524.24 -695.56  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 474.07 32.41 -251.05 -124.11 306.87  
Cash And Cash Equivalents Begin of Year 62.15 29.74 280.79 404.90 98.03  
Cash And Cash Equivalents End Of Year 536.22 62.15 29.74 280.79 404.90  
Source : Dion Global Solutions Limited

Results of GlaxoSmithKline

Results of Pharmaceuticals Sector

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347